(SNOA) Sonoma Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Sonoma Pharmaceuticals | (SNOA) share price targets
Complete technical analysis of Sonoma Pharmaceuticals (SNOA) by charts plus indicators, forecast predictions and share price targets for Sonoma Pharmaceuticals (SNOA)
Sonoma Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-29 View latest technical analysis
10 day averaged volume of Sonoma Pharmaceuticals is 2805901
Date | Daily Closing Price | Open | High | Low | Volume |
29 Thu Aug 2024 | 0.16 | 0.16 | 0.17 | 0.15 | 0.389 times |
28 Wed Aug 2024 | 0.16 | 0.19 | 0.20 | 0.16 | 1.08 times |
27 Tue Aug 2024 | 0.22 | 0.24 | 0.24 | 0.21 | 0.272 times |
26 Mon Aug 2024 | 0.23 | 0.22 | 0.24 | 0.22 | 0.575 times |
23 Fri Aug 2024 | 0.24 | 0.23 | 0.25 | 0.23 | 0.24 times |
22 Thu Aug 2024 | 0.23 | 0.22 | 0.24 | 0.22 | 0.467 times |
21 Wed Aug 2024 | 0.22 | 0.27 | 0.28 | 0.20 | 6.526 times |
20 Tue Aug 2024 | 0.24 | 0.25 | 0.26 | 0.24 | 0.108 times |
19 Mon Aug 2024 | 0.26 | 0.27 | 0.27 | 0.26 | 0.289 times |
16 Fri Aug 2024 | 0.25 | 0.23 | 0.25 | 0.23 | 0.255 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 0.1, for a target of 0.2 or 0.24
Share price targets for Sonoma Pharmaceuticals (SNOA)
Target Type | Value |
Downside Target | 0.14 |
Downside Target | 0.15 |
Downside Target | 0.16 |
Upside Target | 0.19 |
Upside Target | 0.20 |
Upside Target | 0.21 |
Upside Target | 0.24 |
Upside Target | 0.25 |
Upside Target | 0.27 |
Upside Target | 0.28 |
Upside Target | 0.30 |
Upside Target | 0.32 |
Upside Target | 0.33 |
Upside Target | 0.39 |
Upside Target | 0.43 |
Upside Target | 0.47 |
Intraday share price targets for Sonoma Pharmaceuticals (SNOA)
Target Type | Value |
Downside Intraday Target | 0.13 |
Downside Intraday Target | 0.09 |
Upside Intraday Target | 0.22 |
Upside Intraday Target | 0.27 |
Upside Intraday Target | 0.18 |
Weekly technical analysis of Sonoma Pharmaceuticals (SNOA)
Date | Weekly Closing Price | Open | High | Low | Volume |
29 Thu Aug 2024 | 0.16 | 0.22 | 0.24 | 0.15 | 0.304 times |
23 Fri Aug 2024 | 0.24 | 0.27 | 0.28 | 0.20 | 7.532 times |
16 Fri Aug 2024 | 0.25 | 0.25 | 0.25 | 0.20 | 0.568 times |
09 Fri Aug 2024 | 0.25 | 0.28 | 0.32 | 0.21 | 0.633 times |
02 Fri Aug 2024 | 0.32 | 0.35 | 0.43 | 0.27 | 0.993 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Sonoma Pharmaceuticals (SNOA)
Date | Monthly Closing Price | Open | High | Low | Volume |
29 Thu Aug 2024 | 0.16 | 0.37 | 0.39 | 0.15 | 0.385 times |
31 Wed Jul 2024 | 0.37 | 0.21 | 0.47 | 0.21 | 0.47 times |
28 Fri Jun 2024 | 0.21 | 0.20 | 0.30 | 0.16 | 1.777 times |
31 Fri May 2024 | 0.20 | 0.16 | 0.33 | 0.14 | 15.032 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Sonoma Pharmaceuticals (SNOA)
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sonoma Pharmaceuticals in short term and the sell signal is strong.
Sonoma Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sonoma Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.21 and Sonoma Pharmaceuticals (SNOA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sonoma Pharmaceuticals (SNOA) stock. Volume based technical analysis of Sonoma Pharmaceuticals (SNOA) stock is negative.
Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sonoma Pharmaceuticals in short term and the sell signal is strong.
Sonoma Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sonoma Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.21 and Sonoma Pharmaceuticals (SNOA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sonoma Pharmaceuticals (SNOA) stock. Volume based technical analysis of Sonoma Pharmaceuticals (SNOA) stock is negative.
Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.